Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Estimation of Rivaroxaban in Human Plasma

Mudassarahemadkhan Pathan,Ajay Kshirsagar
DOI: https://doi.org/10.1080/22297928.2020.1871069
2020-11-01
Analytical Chemistry Letters
Abstract:A highly selective, sensitive, and reproducible liquid chromatography/tandem mass spectrometry (LC-MS/MS) method was developed and validated for the determination of Rivaroxaban in human plasma using Rivaroxaban D4 as internal standard (IS). Liquid-liquid extraction technique using extraction solvent was used for extraction of analyte and IS. Rivaroxaban and IS were analyzed on Thermo BDS Hypersil C-18 (150 mm × 4.6 mm, 5 μm) column using acetonitrile and 10 mM ammonium acetate buffer in a ratio 80:20 v/v. Mass Detection and quantitation were performed under multiple reaction monitoring using ESI for Rivaroxaban (m/z 436.1 → 145.0) and Rivaroxaban D4 (m/z 440.2 → 144.9), respectively. The advantage of the method includes higher sensitivity (1.00 ng/mL), superior extraction efficiency (>90 %), and small sample volume (200 μL) for processing. The method was linear in the concentration range of 1.00-603.25 ng/mL and method validation was performed as per USFDA guidelines and the results were within the acceptance criteria.
What problem does this paper attempt to address?